Corrigendum: SARS-CoV-2 Omicron variants: burden of disease, impact on vaccine effectiveness and need for variant-adapted vaccines. (2023)
Attributed to:
Phase 1 COVID-19 Immunity - National Core Study
funded by
COVID
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.3389/fimmu.2023.1232965
PubMed Identifier: 37377964
Publication URI: http://europepmc.org/abstract/MED/37377964
Type: Journal Article/Review
Volume: 14
Parent Publication: Frontiers in immunology
ISSN: 1664-3224